Burn and corrosion of other internal organs

ST19_BURN_CORROSION_OTHER_INTERNAL_ORGANS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T28 Cause of death: ICD-10 — T28 2 out of 7 registries used, show all original rules.	117
4. Check minimum number of events None	117
5. Include endpoints None	117
6. Filter based on genotype QC (FinnGen only)	117

Control definitions (FinnGen only)

Control exclude: CD2_BENIGN_FEMALE_GEN_OTH

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T2[6-8]
Name in latin: Combustiones et corrosiones ahiorum organorum internorum

NAME	ST19_BURN_CORROSION_OTHER_INTERNAL_ORGANS
CONTROL_EXCLUDE	CD2_BENIGN_FEMALE_GEN_OTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T28
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T28
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Burn and corrosion of other internal organs based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	117	57	60
Unadjusted period prevalence (%)	0.02	0.02	0.03
Median age at first event (years)	43.59	40.41	46.61

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
107: Matched controls
1071

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

T28.6

ICD-10 Finland

Corrosion of oesophagus

+∞

61.5

T28.5

ICD-10 Finland

Corrosion of mouth and pharynx

+∞

28.4

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

29.8

23.9

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

152.9

23.7

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

7.0

18.7

159

T36

ICD-10 Finland

Poisoning by systemic antibiotics

19.8

17.3

T28.0

ICD-10 Finland

Burn of mouth and pharynx

+∞

17.1

K22.2

ICD-10 Finland

Oesophageal obstruction

86.1

14.0

T54.3

ICD-10 Finland

Toxic effect: Corrosive alkalis and alkali-like substances

+∞

13.8

N05AH03

ATC

olanzapine; systemic

9.3

11.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

6.4

11.4

N05AH04

ATC

quetiapine; oral

5.2

10.7

F32.9

ICD-10 Finland

Depressive episode, unspecified

6.0

10.6

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

26.5

10.5

N05AF03

ATC

chlorprothixene; systemic

13.2

10.0

UJC12

NOMESCO Finland

Flexible oesophagoscopy

60.6

9.8

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

8.1

9.8

WX892

NOMESCO Finland

Monitored bed care

8.8

9.5

N06AX11

ATC

mirtazapine; oral

3.9

9.2

192

N05BA04

ATC

oxazepam; oral

3.9

8.3

143

X58

ICD-10 Finland

Exposure to other specified factors

5.0

8.3

X59

ICD-10 Finland

Exposure to unspecified factor

3.9

7.7

118

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

17.3

7.4

A02BC05

ATC

esomeprazole; systemic

3.2

7.4

250

T28.3

ICD-10 Finland

Burn of internal genitourinary organs

+∞

7.4

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

+∞

7.4

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

184

4.00

11.89

6.2

4.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

163

3.72

10.14

4.3

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

104

3.69

8.10

2.3

1.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

503

3.11

7.46

11.1

5.3

6.25

6.59

mmol/l

1.08

463

(3003396) Base excess in Arterial blood by calculation

3.86

7.34

10.8

15.0

3.00

0.85

mmol/l

1.33

(3044640) Blood type and Crossmatch panel - Blood

244

2.93

7.33

6.0

2.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

131

3.25

7.09

1.9

1.7

980.86

1257.40

nmol/l

1.25

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

366

2.65

6.28

9.8

7.9

1.21

1.22

mmol/l

0.50

297

(3032080) INR in Blood by Coagulation assay

310

2.64

6.17

14.2

9.7

1.13

1.16

inr

0.12

104

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4.68

5.73

1.6

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

5.03

5.39

1.6

1.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

4.84

5.17

2.7

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

392

2.40

5.10

7.0

4.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

192

2.55

5.01

1.5

1.6

1.28

1.16

mg/l

0.07

149

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

5.37

4.87

3.4

2.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

279

2.30

4.49

2.9

3.4

2.33

2.36

mmol/l

0.85

237

(3018418) pH of Serum or Plasma

219

2.34

4.33

4.2

3.9

7.41

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

12.54

3.80

12.3

9.8

0.66

0.51

mmol/l

—

(3022313) Gas panel - Capillary blood

3.71

3.73

2.7

2.1

—

(3000991) Gas panel - Venous blood

3.16

3.62

11.6

10.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3.50

3.45

16.4

24.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.59

3.41

5.5

3.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3.28

3.37

2.0

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

290

2.04

3.33

2.1

1.8

90.35

98.80

pmol/l

0.71

153

(42870588) Differential panel, method unspecified - Blood

290

2.04

3.33

7.3

4.9

—

(3019060) Gas panel - Arterial blood

3.11

3.32

5.6

13.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3.40

3.32

6.7

5.0

26.25

24.08

mmol/l

0.75

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

319

1.99

3.20

6.2

3.3

65.69

31.95

ng/l

0.36

197

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3.23

3.07

14.3

11.2

0.77

0.69

0.25

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3.23

3.07

14.3

10.5

1.73

1.57

0.13

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.54

3.03

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

10.36

3.00

2.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

10.36

3.00

2.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

10.36

3.00

2.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

10.36

3.00

2.6

—

(40768797) Stomach Pathology biopsy report

118

2.30

2.98

1.5

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

4.97

2.97

2.1

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

127

2.23

2.88

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

269

1.95

2.86

4.8

2.5

60.61

53.23

u/l

0.30

244

(3042936) Bacteria identified in Isolate by Culture

107

2.30

2.80

4.3

2.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

8.63

2.77

2.6

2.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

298

1.90

2.74

2.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.52

2.73

1.9

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.52

2.73

2.0

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

207

1.99

2.72

2.3

3.3

344.11

716.42

ng/l

2.02

173

(3007853) Bacteria identified in Skin by Aerobe culture

2.28

2.55

4.0

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2.38

2.45

4.4

2.3

0.21

0.23

g/l

0.40

(3012544) pH of Venous blood

2.56

2.40

2.0

4.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.51

2.32

2.1

1.5

—

(3019225) pH of Specimen

2.42

2.29

7.6

3.9

—

(3027315) Oxygen [Partial pressure] in Blood

4.07

2.29

9.1

2.6

9.34

8.50

kpa

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

4.07

2.29

2.3

1.9

—

(3013290) Carbon dioxide [Partial pressure] in Blood

4.07

2.29

9.1

2.6

5.00

4.89

kpa

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

180

1.90

2.20

1.6

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

4.45

2.18

2.3

2.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

144

1.94

2.06

4.4

2.9

911.22

90.56

ng/l

0.44

102

(3013650) Neutrophils [#/volume] in Blood by Automated count

547

1.70

2.03

16.3

8.4

4.16

4.02

e9/l

0.17

487

(3013512) EKG study

243

1.76

2.03

5.6

3.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

3.48

2.00

1.3

2.7

2.70

3.41

g/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

236

1.76

1.98

1.9

2.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

4.30

1.84

7.8

1.8

1.66

1.79

mmol/l

—

(3042631) Mycobacterium sp identified in Specimen

4.30

1.84

2.8

1.7

—

(1616796) Gas panel - Central venous blood

3.45

1.77

4.5

3.3

—

(3000494) Fungus identified in Specimen by Culture

1.99

1.73

2.2

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

3.97

1.73

1.0

1.4

—

(40761535) Cells panel - Urine sediment

2.23

1.73

2.6

3.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.61

1.63

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

2.80

1.61

21.1

4.2

—

(3003694) ABO and Rh group [Type] in Blood

268

1.62

1.56

1.7

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.28

1.56

11.8

2.8

—

(3022806) Fractional oxyhemoglobin in Capillary blood

3.43

1.54

7.4

1.5

93.22

92.21

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2.82

1.45

1.3

2.8

208.33

216.05

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2.03

1.39

6.2

4.1

1.20

1.23

mmol/l

0.75

(3016879) Cocaine [Presence] in Urine

2.08

1.38

16.8

2.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2.23

1.38

3.1

2.0

—

4461.38

u/l

—

(3011288) Drugs identified in Urine by Screen method

2.23

1.38

11.6

4.2

—

(40758558) Short blood count panel - Blood

223

1.60

1.37

8.8

5.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

1.96

1.36

3.2

4.4

0.00

0.30

—

(3048689) Calprotectin [Mass/mass] in Stool

124

1.74

1.31

1.7

2.4

48.20

101.45

ug/g

1.77

(3027944) Amphetamines [Presence] in Urine

2.01

1.28

16.8

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

2.01

1.28

16.8

2.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

391

1.49

1.26

2.7

2.4

126.30

100.55

ug/l

0.58

356

(3002582) Erythrocytes [#/volume] in Urine

263

1.53

1.25

3.4

2.9

17.33

281.84

e6/l

0.60

215

(3027008) Opiates [Presence] in Urine

1.94

1.18

16.8

2.6

—

(3028300) Cannabinoids [Presence] in Urine

1.94

1.18

16.8

2.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.99

1.16

1.0

—

(3025159) Blasts/100 leukocytes in Blood

1.88

1.16

2.4

4.5

0.00

0.47

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

232

1.52

1.14

1.9

1.6

—

(3018095) Leukocytes [#/volume] in Urine

305

1.47

1.13

3.8

3.4

10.74

55.68

e6/l

1.80

224

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.34

1.12

1.0

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

712

1.45

1.03

3.4

3.3

—

(36660697) Celiac disease serology panel - Serum

1.77

1.00

1.2

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

632

1.41

0.99

5.5

3.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

221

1.48

0.99

1.4

1.2

0.88

0.91

u/ml

0.03

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.99

0.0

1.5

—

0.23

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.99

0.0

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.99

0.0

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

0.00

0.99

0.0

1.5

—

1.18

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

104

966

1.69

0.97

32.9

11.0

20.27

19.77

mg/l

0.08

736

(3025941) Bacteria identified in Stool by Culture

1.83

0.97

1.2

—

(4094501)

0.00

0.96

0.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

103

1.64

0.93

7.1

6.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1.77

0.93

3.5

4.5

0.20

0.40

—

(40761511) CBC panel - Blood by Automated count

107

1004

1.77

0.92

31.3

11.3

—

(3029937) Albumin [Presence] in Urine by Test strip

252

1.43

0.91

4.8

3.6

0.00

estimate

0.00

(3017181) Myelocytes/100 leukocytes in Blood

1.70

0.89

3.4

4.3

0.20

0.91

—

(3044889) 12 lead EKG panel

629

1.38

0.89

6.6

3.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.98

0.85

2.3

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

1.79

0.84

1.4

1.2

91.63

661.89

u/ml

—

(4010399)

1.79

0.82

1.1

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

886

1.47

0.81

21.5

10.7

93.96

88.08

ml/min/173m2

1.59

703

(21494755) Public health laboratory ask at order entry panel

131

0.58

0.79

1.0

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.78

0.0

1.2

—

(3021589) Normoblasts [#/volume] in Blood

410

1.34

0.77

20.3

9.0

0.00

e9/l

0.71

338

(40768804) Tissue Pathology biopsy report

344

1.34

0.76

1.8

1.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2.13

0.75

1.8

1.7

—

(3026008) Bacteria identified in Urine by Culture

237

1.36

0.68

4.2

2.5

—

(3030467) Casts [#/volume] in Urine by Automated count

229

1.35

0.65

3.4

2.7

0.78

0.25

e6/l

0.46

180

(3012516) Albumin [Mass/volume] in Urine

219

0.69

0.65

3.2

3.3

16.65

68.95

mg/l

2.33

149

(3019150) Specific gravity of Urine by Refractometry

211

1.36

0.65

6.6

3.6

1.02

kg/l

—

(3020891) Body temperature

1.76

0.64

11.4

3.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

115

1.45

0.60

2.3

2.5

6.50

1.82

e6/l

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.65

0.56

5.7

2.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

117

1.43

0.56

2.1

2.4

0.75

1.08

e6/l

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1.56

0.54

1.4

1.2

117.60

174.88

iu/ml

—

(3020682) Albumin/Creatinine [Ratio] in Urine

233

0.73

0.54

2.9

4.2

1.42

9.36

mg/mmol

2.94

157

(3013707) Erythrocyte sedimentation rate by Westergren method

676

1.26

0.53

5.6

3.5

11.78

9.84

mm/h

0.50

621

(36304419) Bacteria [Presence] in Urine

229

1.29

0.50

3.5

2.6

—

(3035350) Ketones [Presence] in Urine by Test strip

459

1.24

0.50

4.2

3.3

0.00

estimate

0.00

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

118

0.65

0.48

1.4

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

174

0.72

0.47

2.6

0.71

0.77

ug/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

142

1.32

0.41

1.6

1.4

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.41

0.0

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.41

0.0

2.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.49

0.41

1.8

2.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.39

0.0

3.3

—

51.79

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

167

0.75

0.37

2.5

2.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

145

0.73

0.37

1.5

1.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

286

1.21

0.36

3.5

3.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1.32

0.33

1.5

—

(3015736) pH of Urine

357

1.18

0.32

4.8

3.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

0.69

0.32

1.9

2.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

110

0.71

0.30

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

903

1.21

0.30

5.6

4.0

5.92

5.82

mmol/l

0.20

842

(3007164) IgA [Mass/volume] in Serum or Plasma

197

1.21

0.28

1.3

1.4

1.87

2.74

g/l

1.39

119

(3011397) Hemoglobin [Presence] in Urine by Test strip

188

1.21

0.28

4.1

3.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

905

1.20

0.27

4.6

3.7

1.51

1.31

mmol/l

1.17

847

(3009261) Glucose [Presence] in Urine by Test strip

471

1.15

0.26

4.6

3.3

0.00

estimate

0.00

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.73

0.25

1.5

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

374

1.15

0.25

4.4

3.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.69

0.25

1.7

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

103

0.76

0.22

1.4

1.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.6

—

16.26

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.21

0.0

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

(4268621)

0.00

0.21

0.0

1.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.21

0.0

2.0

—

13.15

—

(4035726)

1.12

0.16

1.5

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

181

0.87

0.15

2.6

2.5

—

(3022145) Colonoscopy Study observation

1.16

0.10

1.2

1.4

—

(40761536) Microorganisms panel - Urine sediment

1.16

0.10

5.0

3.3

—

(3000492) Spirometry study

1.14

0.08

1.3

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

936

1.08

0.07

4.6

4.1

1.37

1.43

mmol/l

0.71

877

(40760892) CBC W Ordered Manual Differential panel - Blood

244

0.93

0.07

5.5

4.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

151

0.92

0.05

1.4

1.3

6.52

7.95

u/ml

—

(3009542) Hematocrit [Volume Fraction] of Blood

908

1.06

0.05

29.9

11.9

39.53

41.43

1.26

716

(1761868) Lipid panel - Serum or Plasma

397

0.97

0.01

2.9

2.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

464

1.02

0.00

5.0

4.5

0.00

estimate

0.00

(3002256) Pathology report gross observation

1.05

0.00

1.4

1.2

—

(1175426) CD3 cells/100 lymphocytes in Blood

0.00

0.0

1.4

—

69.00

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

12.38

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

0.94

0.00

1.0

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.29

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

0.0

1.4

—

9.25

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

10.20

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

0.0

1.2

—

127.20

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

1.8

—

(3004451) EKG impression Narrative

0.00

0.0

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.0

2.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.0

3.8

—

(3044941) Cell count panel - Synovial fluid

0.00

0.0

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

9.57

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.9

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

5.56

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

2.5

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

0.0

2.5

—

5.70

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.81

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

0.00

0.0

2.5

—

2.97

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

559.33

—

(4146454)

0.00

0.0

2.7

—

(3017569) Oxygen content in Arterial blood

0.00

0.0

10.6

—

(3022621) pH of Urine by Test strip

1.02

0.00

6.6

2.2

—

(3015183) Erythrocyte sedimentation rate

0.00

0.0

1.1

—

(3051651) Icteric interference index of Serum or Plasma

0.00

0.0

2.8

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.7

—

10.64

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.00

0.0

2.7

—

56.00

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

0.0

5.4

—

52.57

—

(44813793)

0.00

0.0

1.0

—

(4027681)

0.00

0.0

1.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.2

—

(3011648) Oxygen content in Venous blood

0.00

0.0

3.0

—

10.95

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_BURN_CORROSION_OTHER_INTERNAL_ORGANS – Burn and corrosion of other internal organs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Burn and corrosion of other internal organs

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Burn and corrosion of other internal organs (ST19_BURN_CORROSION_OTHER_INTERNAL_ORGANS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints